PRODUCT
For EU (CE marking):
DISCLAIMER:
Indications
of one device may vary in different markets due to regulatory differences in
each market.
The
contents below are in accordance with the CE marking of the medical device
under EU Medical Devices Directive (MDD 93/42/EEC, as amended by Directive
2007/47/EC).
The
claims under this section of the website are not supported for US 510(k) or
Korean MFDS permission purposes.
Regenomer®
is:
-
Sponge-like absorbable and porous collagen matrix.1)
-
Made from purified type I atelocollagen derived from porcine skin sources in
South Korea.2)
-
Physically crosslinked.3)
-
Biocompatible.4)
-
Recommended resorption time is 4 weeks.5)
Indications
1.
Bone filling augmentation for use in filling of extraction sockets.6)
2.
To stop bleeding after an odontectomy.6)
3.
To cover the surface of a wound created by an odontectomy.6)
4.
Wound dressing for dental surgery.6)
The
three types of Regenomer® (syringe, plug, and block) are the same
material intended to be used the same way but only in different shapes to meet
clinicians' preference in shaping and modification according to defect sites.
References
1)
Physical and Chemical Test of Regenomer (Bench Test), NIBEC Co., Ltd., data on
file.
2)
Raw Materials (Regenomer), NIBEC Co., Ltd., data on file.
3)
Manufacturing (Regenomer), NIBEC Co., Ltd., data on file.
4)
Biocompatibility Test, NIBEC Co., Ltd., data on file.
5)
Performance Test - Animal, NIBEC Co., Ltd., data on file.
6)
Clinical Evaluation Report (Regenomer), NIBEC Co., Ltd., data on file.
For USA (510(k)):
DISCLAIMER:
Indications
of one device may vary in different markets due to regulatory differences in
each market.
The
contents below are in accordance with the US 510(k) Premarket Notification
requirements.
The
claims under this section of the website are not supported for EU CE marking or
Korean MFDS permission purposes.
The
Regenomer® is in general recommended for the filling of extraction
sockets and periodontal defect. The indication for use depending on the device
format is further classified as described in following table.
Format |
Syringe |
Plug |
Block |
Indication for use |
- Filling of periodontal defects in conjunction with products
intended for Guided Tissue Regeneration (GTR)
- Filling of peri-implant defects in conjunction with products
intended for Guided Bone Regeneration (GBR) |
- Filling of extraction sockets
- Augmentation or reconstructive treatment of the alveolar ridge
- Elevation of maxillary sinus floor |
- Augmentation or reconstructive treatment of the alveolar ridge
- Elevation of maxillary sinus floor |
For Korea (MFDS permission):
DISCLAIMER:
Indications of one
device may vary in different markets due to regulatory differences in each
market.
The contents below are
in accordance with the medical device permission from the Korean Ministry of
Food and Drug Safety.
In addition, the claims
below have been deliberated by the Medical Device Advertisement
Pre-deliberation Committee of the Korea Medical Devices Industry Association.
The claims under this section of the website are not
supported for EU CE
marking or US
510(k) purposes.
“This product is a
'medical device'. Please carefully read 'Precautions' and ‘Instruction' before
use.”
Regenomer is a
sponge-type periodontal tissue regeneration graft composed of collagen. Filling
the periodontal tissue defect site with collagen, a major protein constituting
bone tissue, secures a space for the surrounding osteoblasts to grow and
creates a favorable environment for bone regeneration. Osteoblasts can also be
used in combination.
Preventing penetration
of food and other foreign substances into extraction socket
Wound protection
Acceleration of new
tissue growth
Prevention of soft
tissue retraction in the extraction socket (gingival recession prevention)
Prevention of alveolar
bone absorption
Deliberation No.:
2015-I10-13-0877